You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 256 No. 6, August 8, 1986 TABLE OF CONTENTS
  JAMA
  •  Online Features
  Letters
 This Article
 •References
 •Full text PDF
 •Correction
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citing articles on HighWire
 •Citing articles on Web of Science (17)
 •Contact me when this article is cited
 Related Content
 •Similar articles in JAMA
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Diploid Cell Measles Vaccine

Jorge Fernández de Castro, MD; José Luis Valdespino Gómez, MD; José Luis Díaz Ortega, MD; Ma. Luisa Zárate Aquino, MD
Secretaria de Salud; Secretaria de Salud;Instituto de Salubridad Mexico City

JAMA. 1986;256(6):714.

Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

To the Editor.—

Dr Albert Sabin and one of us (J.F.D.)1,2 recently reported seroconversion in infants administered measles vaccine of human diploid cells (HDCs) that contained the Ikic (Edmonston-Zagreb) strain and 1% human albumin, or chick embryo fibroblast (CEF) vaccine that contained the Edmonston-Schwartz strain by cutaneous or aerosol routes. In that study, we used enzyme-linked immunosorbent assay and plaque neutralization tests to demonstrate seroconversion. In this letter we report a further study in Formula which antibody was measured using the more standard hemagglutination inhibition. This double-blind study was carried out in children aged 6 to 8 months residing in two poor urban areas of Mexico City between October 1983 and April 1984.

Report of a Case.—

One hundred seventy-two children received HDC vaccine manufactured in Mexico: 117 via aerosol (titer of virus, 105.2 50% tissue culture infective dose per milliliter), and 55 by injection (titer of virus, 10 . . . [Full Text PDF of this Article]



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?






HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1986 American Medical Association. All Rights Reserved.